Literature DB >> 6814791

Colorimetric assays for N-acetyl-beta-D-glucosaminidase and beta-D-galactosidase in human urine using newly-developed omega-nitrostyryl substrates.

C T Yuen, R G Price, L Chattagoon, A C Richardson, P F Praill.   

Abstract

(1) The synthesis of 2-methoxy-4-(2'-nitrovinyl)-phenyl 2-acetamido-2-deoxy-beta-D-glucopyranoside (MNP-GlcNAc) and 2-methoxy-4-(2'nitrovinyl)-phenyl beta-D-galactopyranoside (MNP-Gal) as substrates for the assay of NAG and beta-d-galactosidase are described. (2) beta-Glycosidase activities were determined in random urine samples from normal males and females aged between 12 and 87 years and patients with renal disease. (3) Both the MNP N-acetylglucosaminide and MNP galactoside were stable indefinitely, if stored in the solid state at 4 degree C in the dark. (4) The effect of urinary inhibitors was minimized by diluting the urine in the assay procedure. A simple assay procedure has been developed using MNP substrates. A good correlation was found with established assays using 4-methylumbelliferyl and p-nitrophenyl glycosides. (5) The assay was readily automated and a good correlation was found between the automated and manual methods. (6) The assay of urinary glycosidase activity with MNP substrates is simple to perform and has been used successfully in the clinical chemistry laboratory.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814791     DOI: 10.1016/0009-8981(82)90387-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Lack of effect of lactose digestion status on baseline fecal micoflora.

Authors:  Andrew Szilagyi; Ian Shrier; George Chong; Jung Sung Je; Sunghoon Park; Debra Heilpern; Catherine Lalonde; Louis-Francois Cote; Byong Lee
Journal:  Can J Gastroenterol       Date:  2009-11       Impact factor: 3.522

2.  Influence of pigments and pH of urine on the determination of N-acetyl-beta-D-glucosaminidase activity with 2-methoxy-4-(2'-nitrovinyl)-phenyl-N-acetyl-beta-D-glucosaminide.

Authors:  Jelena M Aćimović; Vesna B Jovanović; Ljuba M Mandić
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Risk assessment of leukaemia and occupational exposure to benzene.

Authors:  G M Swaen; J M Meijers
Journal:  Br J Ind Med       Date:  1989-12

4.  Improved parameters of lactose maldigestion using lactulose.

Authors:  A Szilagyi; J Rivard; K Fokeeff
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

5.  Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?

Authors:  F Briet; P Pochart; P Marteau; B Flourie; E Arrigoni; J C Rambaud
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

6.  Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).

Authors:  C Florent; B Flourie; A Leblond; M Rautureau; J J Bernier; J C Rambaud
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination.

Authors:  V B Jovanović; V S Dimitrijević-Srecković; Ljuba M Mandić
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

8.  Changes in urinary enzyme levels following the use of antihypertensive agents in patients with essential hypertension.

Authors:  D K Obatomi; S C Mogbo; F I Anjorin; A A Jigam
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

9.  Subclinical affection of liver and kidney function and solvent exposure.

Authors:  K Rasmussen; C H Brogren; S Sabroe
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

10.  Effect of kidney function and disease status on urinary tissue factor measurements.

Authors:  B A Lwaleed; P S Bass; M E Rogerson; J L Francis; M Chisholm
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.